April 12, 2022
Dirix L et al. Breast Cancer Research and Treatments, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
You might also be interested by
CellTalk Blog
CROs vs. CMOs vs. CDMOs: Understanding the Differences in Outsourcing Partners
June 10, 2025
More infoCellTalk Blog
What is a Contract Research Organization (CRO), and How Do You Choose the Right One?
June 4, 2025
More infoPosters
Efficient tracking of electronic noise in BD LSR Fortessa without routine baseline checks
May 30, 2025
More infoCellTalk Blog
Optimizing T-Cell Engager (TCE) Development: Insights You Need for Clinical and Regulatory Success
May 27, 2025
More info